Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome
- 4 December 2020
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (5), 617-625
- https://doi.org/10.1136/annrheumdis-2020-217470
Abstract
Objectives Systemic juvenile idiopathic arthritis (SJIA) confers high risk for macrophage activation syndrome (MAS), a life-threatening cytokine storm driven by interferon (IFN)-γ. SJIA monocytes display IFN-γ hyper-responsiveness, but the molecular basis of this remains unclear. The objective of this study is to identify circulating monocyte and bone marrow macrophage (BMM) polarisation phenotypes in SJIA including molecular features contributing to IFN response. Methods Bulk RNA-seq was performed on peripheral blood monocytes (n=26 SJIA patients) and single cell (sc) RNA-seq was performed on BMM (n=1). Cultured macrophages were used to define consequences of tripartite motif containing 8 (TRIM8) knockdown on IFN-γ signalling. Results Bulk RNA-seq of SJIA monocytes revealed marked transcriptional changes in patients with elevated ferritin levels. We identified substantial overlap with multiple polarisation states but little evidence of IFN-induced signature. Interestingly, among the most highly upregulated genes was TRIM8, a positive regulator of IFN-γ signalling. In contrast to PBMC from SJIA patients without MAS, scRNA-seq of BMM from a patient with SJIA and MAS identified distinct subpopulations of BMM with altered transcriptomes, including upregulated IFN-γ response pathways. These BMM also showed significantly increased expression of TRIM8. In vitro knockdown of TRIM8 in macrophages significantly reduced IFN-γ responsiveness. Conclusions Macrophages with an ‘IFN-γ response’ phenotype and TRIM8 overexpression were expanded in the bone marrow from an MAS patient. TRIM8 is also upregulated in SJIA monocytes, and augments macrophage IFN-γ response in vitro, providing both a candidate molecular mechanism and potential therapeutic target for monocyte hyper-responsiveness to IFNγ in cytokine storms including MAS.Funding Information
- Systemic JIA Foundation
- National Institutes of Health (K08-AR072075, P30-AR070549, R01-AR059049)
- Cincinnati Children's Research Foundation (ARC Grant)
- Jellen Family Foundation
This publication has 47 references indexed in Scilit:
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndromeBlood, 2018
- Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArthritis Research & Therapy, 2017
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic ArthritisAnnals Of The Rheumatic Diseases, 2016
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questionsNature Reviews Rheumatology, 2011
- Gene expression profiling of peripheral blood from patients with untreated new‐onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndromeArthritis & Rheumatism, 2007
- The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritisArthritis & Rheumatism, 2007
- Systemic juvenile idiopathic arthritis: diagnosis, management, and outcomeNature Clinical Practice Rheumatology, 2006
- Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockadeThe Journal of Experimental Medicine, 2005
- Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five casesThe Journal of Pediatrics, 1996
- Macrophage activation syndrome in systemic juvenile rheumatoid arthritisThe Journal of Pediatrics, 1996